Chiadi E Ndumele reported that there were no significant differences between the ability of the apoB/apoAΙ ratio and the ability of the non-HDL-C/HDL-C ratio to predict coronary heart disease in the setting of MetS [31]. Here, APOB is linked to metabolic syndrome.